Projectes destacats

Tailored immunotherapies in 3D models of Follicular Lymphoma (TAIFOL)

Investigador/a principal: Patricia Pérez Galán.
Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundació La Marató de TV3 .

Durada: 01/04/2020
Characterization of duvelisib activity in follicular lymphoma and macrophages crosstalk

Investigador/a principal: Patricia Pérez Galán.
Finançador: Janssen Pharmaceuticals ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Verastem .

Durada: 01/01/2020 - 31/12/2020
Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET

Investigador/a principal: Patricia Pérez Galán, Maria Cinta Cid Xutgla, Patricia Pérez Galán.
Finançador: Ministerio de Economia y Competitividad (MINECO) (Patrocinador).

Codi: SAF 2017- 88275-R.

Durada: 01/01/2018 - 31/12/2020
Cross-border network of personalized immunotherapies in Non-Hodgkin Lymphoma -IMLINFO (POCTEFA-INTERREG). Proyecto financiado por Fondo Europeo de Desarrollo Regional (FEDER)

Investigador/a principal: Patricia Pérez Galán.
Finançador: INTERREG V-POCTEFA .

Codi: EFA281/16.

Durada: 01/01/2018 - 31/12/2021
MICROENTARGET: Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention.

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); MINECO .

Durada: 01/12/2017
Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention

Investigador/a principal: Patricia Pérez Galán.
Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Ministerio de Economia y Competitividad (MINECO) ; PROYECTOS I+D+I RETOS INVESTIGACIÓN (Programa financiador competitivo).

Codi: SAF2014-57708-R.

Durada: 01/10/2015 - 30/09/2018
Characterization of the mechanisms of microenvironment-derived resistance to GS-1101/ Idelalisib in follicular lymphoma. Analysis of therapeutic potential combination with other kinases inhibitors

Investigador/a principal: Patricia Pérez Galán.
Finançador: Gilead .

Durada: 01/07/2014
HuMax-CD38 (Daratumumab) activity in in vivo models of MCL and FL: Analysis of possible combinatorial regimens

Investigador/a principal: Patricia Pérez Galán.
Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Janssen Pharmaceuticals .

Durada: 01/06/2014
Targeting proliferation and tumor-microenvironment interactions using bifunctional compounds against cannabinoid and chemokine receptors

Investigador/a principal: Patricia Pérez Galán.
Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Fundacio la Marato TV3 ; http://www.tv3.cat/marato/es/projectes_financats_2012 (Programa financiador competitivo).

Durada: 26/05/2014 - 26/05/2017
Microenvironment Interactions in the pathogenesis of lymphoid neoplasms and chronic inflammatory disorders. Identification of biomarkers and design of new therapeutic strategies

Finançador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); Instituto de Salud Carlos III ; Proyectos transversales ISCIII (Programa financiador competitivo).

Codi: PIE1313/00033.

Durada: 01/03/2014 - 01/03/2017

La recerca d'aquest grup es pot dur a terme gràcies als finançadors.

Projectes destacats

Tailored immunotherapies in 3D models of Follicular Lymphoma (TAIFOL)

Characterization of duvelisib activity in follicular lymphoma and macrophages crosstalk

Multi-cellular interactions in the progression of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate targeted immune therapies -3DIMMUNETARGET

Cross-border network of personalized immunotherapies in Non-Hodgkin Lymphoma -IMLINFO (POCTEFA-INTERREG). Proyecto financiado por Fondo Europeo de Desarrollo Regional (FEDER)

MICROENTARGET: Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention.

Crosstalk between lymphocytes and their microenvironment in chronic inflammatory diseases and lymphoproliferative disorders as a target for new therapeutic intervention

Characterization of the mechanisms of microenvironment-derived resistance to GS-1101/ Idelalisib in follicular lymphoma. Analysis of therapeutic potential combination with other kinases inhibitors

HuMax-CD38 (Daratumumab) activity in in vivo models of MCL and FL: Analysis of possible combinatorial regimens

Targeting proliferation and tumor-microenvironment interactions using bifunctional compounds against cannabinoid and chemokine receptors

Microenvironment Interactions in the pathogenesis of lymphoid neoplasms and chronic inflammatory disorders. Identification of biomarkers and design of new therapeutic strategies

Finançadors principals